Dose Response and Pharmacokinetics of Tofacitinib (CP-690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis
口服 Janus 激酶抑制剂托法替尼 (CP-690,550) 治疗慢性斑块状银屑病的剂量反应和药代动力学
期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1038/psp.2013.16
Vlasakakis, G; Comets, E; Keunecke, A; Gueorguieva, I; Magni, P; Terranova, N; Della Pasqua, O; de Lange, E C; Kloft, C; Masimirembwa, C; Hasler, J A; van der Graaf, P H; Tan, H; Gupta, P; Harness, J; Wolk, R; Chapel, S; Menter, A; Strober, B; Langley, RG; Krishnaswami, S; Papp, KA
